LucyDx
About this raise
LucyDx, with a valuation of $8 million, is raising funds on NetCapital. It is a medical technology company developing a diagnostic headset for the early detection of diabetic retinopathy. The non-invasive and compact headset of LucyDx is based on an electroretinogram and aims to prevent blindness through early detection. LucyDx has pinpointed its target market, validated demand, and is working with researchers at Emory University, Georgia Tech, and the VA Atlanta Medical Center. Andreas Inmann and Antoin Johnson founded LucyDx in February 2021. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1 million. The campaign proceeds will be used for product development, regulatory affairs, operations and payroll, prototyping, and testing.
Investment Overview
Invested : $12,192
Deal Terms
Total Commitments
- Platform
- Netcapital
- Start Date
- 03/30/2023
- Close Date
- 04/30/2025
$10,000
$608,000
$104
Equity - Common
Early Stage
RegCF
$8.00
$8,000,000
Company & Team
Company
- Year Founded
- 2021
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B2C
- Margin
- Medium
- Capital Intensity
- High
Financials
-
Revenue
-
$0
as of FY2023
- Monthly Burn
-
$1,323
as of FY2023
-
Runway
-
6.8 months
as of FY2023
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $4,000
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 04/30/2025 | Netcapital | $8,000,000 | $12,192 | Equity - Common | Funded | RegCF |